Chris Xu

Chris Xu is an accomplished leader in the life sciences sector, currently serving as the Chairman of HealthBanks Biotech, a CDMO biomanufacturer and premier cell banking network, since July 2019. In addition, Chris Xu functions as a Venture Advisor at WI Harper Group, focusing on life science investments. As the Chairman and CEO of ThermoGenesis Holdings, Inc., since March 2016, Chris Xu oversees a market leader in automated cellular processing technologies. Furthermore, Chris Xu is a member of the Board of Directors at Peking University and holds the position of Adjunct Professor at the Institute of Molecular Medicine. Previously, Chris Xu founded and chaired Boyalife, a diversified life science holding company, from July 2009 to November 2016. Educational credentials include a PhD in Immunology from Washington University School of Medicine in St. Louis and an Executive MBA from Emory University's Goizueta Business School.